| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Quanterix Corp | Director | Common Stock | 255K | $2.74M | $10.76 | Jan 2, 2025 | Held by trust |
| REPLIGEN CORP | Director | Common Stock | 5.59K | $695K | $124.38 | Aug 8, 2025 | Direct |
| Quanterix Corp | Director | Common Stock | 36.9K | $397K | $10.76 | Jan 2, 2025 | Direct |
| HOLOGIC INC | Director | Common Stock | 5.45K | $301K | $55.24 | May 7, 2025 | Revocable Trust |
| STANDARD BIOTOOLS INC. | Director | Common Stock | 104K | $264K | $2.54 | Oct 20, 2023 | Direct |
| Azenta, Inc. | Director | Restricted Stock Unit | 11.4K | $211K | $52.32 | Feb 7, 2025 | Direct |
| REPLIGEN CORP | Director | Common Stock | 1.8K | $202K | $112.13 | Aug 8, 2025 | By Martin D. Madaus 2011 Revocable Trust |
| HOLOGIC INC | Director | Common Stock | 2.21K | $126K | $57.16 | May 7, 2025 | Direct |
| STANDARD BIOTOOLS INC. | Director | Stock Option (Right to Buy) | 35.4K | $65.8K | $1.86 | Jun 14, 2023 | Direct |
| REPLIGEN CORP | Director | Common Stock | 11 | $1.37K | $124.38 | Aug 8, 2025 | Spouse Trust |
| Quanterix Corp | Director | Stock Option (Right to Buy) | 15.8K | Jan 2, 2025 | Direct | ||
| HOLOGIC INC | Director | Non-qualified Stock Option (Right to Buy) | 5.54K | Feb 26, 2025 | Direct | ||
| REPLIGEN CORP | Director | Stock Option (Right to Buy) | 1.8K | May 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RGEN | REPLIGEN CORP | Aug 8, 2025 | 1 | $202K | 4 | Aug 12, 2025 | Director |
| RGEN | REPLIGEN CORP | May 15, 2025 | 2 | $0 | 4 | May 19, 2025 | Director |
| HOLX | HOLOGIC INC | May 7, 2025 | 1 | $301K | 4 | May 9, 2025 | Director |
| HOLX | HOLOGIC INC | Feb 26, 2025 | 2 | $0 | 4 | Feb 28, 2025 | Director |
| AZTA | Azenta, Inc. | Feb 7, 2025 | 0 | $0 | 4/A | Nov 25, 2025 | Director |
| QTRX | Quanterix Corp | Jan 2, 2025 | 2 | $0 | 4 | Jan 6, 2025 | Director |
| HOLX | HOLOGIC INC | Dec 9, 2024 | 1 | $0 | 4 | Dec 11, 2024 | Director |
| HOLX | HOLOGIC INC | Dec 6, 2024 | 0 | $0 | 3 | Dec 11, 2024 | Director |
| AZTA | Azenta, Inc. | Nov 19, 2024 | 1 | $201K | 4 | Nov 19, 2024 | Director |
| RGEN | REPLIGEN CORP | Jun 14, 2024 | 2 | $202K | 4 | Jun 14, 2024 | Director |
| RGEN | REPLIGEN CORP | May 16, 2024 | 2 | $0 | 4 | May 20, 2024 | Director |
| AZTA | Azenta, Inc. | Feb 12, 2024 | 1 | $163K | 4 | Feb 13, 2024 | Director |
| AZTA | Azenta, Inc. | Jan 30, 2024 | 0 | $0 | 3 | Feb 2, 2024 | Director |
| QTRX | Quanterix Corp | Jan 2, 2024 | 2 | $0 | 4 | Jan 4, 2024 | Director |
| LAB | STANDARD BIOTOOLS INC. | Oct 20, 2023 | 1 | $4K | 4 | Oct 20, 2023 | Director |
| LAB | STANDARD BIOTOOLS INC. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| RGEN | REPLIGEN CORP | May 18, 2023 | 2 | $0 | 4 | May 22, 2023 | Director |
| RGEN | REPLIGEN CORP | Mar 24, 2023 | 4 | $240K | 4 | May 8, 2023 | Director |
| LAB | STANDARD BIOTOOLS INC. | Feb 20, 2023 | 1 | $0 | 4 | Feb 22, 2023 | Director |
| RGEN | REPLIGEN CORP | Feb 6, 2023 | 0 | $0 | 3/A | May 5, 2023 | Director |
| RGEN | REPLIGEN CORP | Feb 6, 2023 | 3 | $0 | 4 | Feb 8, 2023 | Director |
| QTRX | Quanterix Corp | Jan 3, 2023 | 2 | $0 | 4 | Jan 4, 2023 | Director |
| QTRX | Quanterix Corp | Aug 10, 2022 | 1 | $756K | 4 | Aug 10, 2022 | Director |
| LAB | STANDARD BIOTOOLS INC. | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
| LAB | STANDARD BIOTOOLS INC. | Apr 4, 2022 | 2 | $0 | 4 | Apr 6, 2022 | Director |
| LAB | STANDARD BIOTOOLS INC. | Apr 4, 2022 | 0 | $0 | 3 | Apr 6, 2022 | Director |
| QTRX | Quanterix Corp | Jan 3, 2022 | 3 | $18.1K | 4 | Jan 5, 2022 | Director |
| QTRX | Quanterix Corp | Oct 1, 2021 | 1 | $18.1K | 4 | Oct 5, 2021 | Director |
| QTRX | Quanterix Corp | Jul 1, 2021 | 1 | $18.1K | 4 | Jul 6, 2021 | Director |